Compile Data Set for Download or QSAR
Report error Found 465 Enz. Inhib. hit(s) with Target = 'Epidermal growth factor receptor [1-18,20-1210,T790M,C797S]'
TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561447(US11390625, Compound 20 | US11390625, Example 20)
Affinity DataIC50: 0.0510nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561449(US11390625, Compound 23 | US11390625, Example 23)
Affinity DataIC50: 0.0520nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM537926(US11248003, Example 1)
Affinity DataIC50: 0.0800nMAssay Description:The inhibitory activity on a C797S-containing epidermal growth factor receptor (EGFR) kinase and an MET kinase was measured for compound 1 obtained i...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538108(US11253516, Example 10)
Affinity DataIC50: 0.200nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538135(US11253516, Example 37)
Affinity DataIC50: 0.200nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538139(US11253516, Example 41)
Affinity DataIC50: 0.200nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701602(US20240352053, Compound Control Example 1)
Affinity DataIC50: 0.200nMMore data for this Ligand-Target Pair
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561455(US11390625, Compound 41 | US11390625, Example 41)
Affinity DataIC50: 0.212nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561454(US11390625, Compound 34 | US11390625, Example 34)
Affinity DataIC50: 0.218nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561456(US11390625, Compound 44 | US11390625, Example 44)
Affinity DataIC50: 0.281nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538134(US11253516, Example 36)
Affinity DataIC50: 0.300nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538137(US11253516, Example 39)
Affinity DataIC50: 0.300nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538140(US11253516, Example 42)
Affinity DataIC50: 0.300nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701603(US20240352053, Compound Formula I)
Affinity DataIC50: 0.300nMMore data for this Ligand-Target Pair
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538138(US11253516, Example 40)
Affinity DataIC50: 0.400nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM707579(US20240409609, Compound 109)
Affinity DataIC50: 0.406nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561441(US11390625, Compound 9 | US11390625, Example 9)
Affinity DataIC50: 0.485nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561443(US11390625, Compound 16 | US11390625, Example 16)
Affinity DataIC50: 0.491nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547815(WO2022090481, Example I-030)
Affinity DataIC50: 0.5nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538136(US11253516, Example 38)
Affinity DataIC50: 0.5nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547876(WO2022090481, Example I-095)
Affinity DataIC50: 0.600nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547877(WO2022090481, Example I-096)
Affinity DataIC50: 0.600nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538141(US11253516, Example 43)
Affinity DataIC50: 0.600nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561437(US11390625, Example 2)
Affinity DataIC50: 0.613nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561451(US11390625, Compound 26 | US11390625, Example 26)
Affinity DataIC50: 0.679nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547878(WO2022090481, Example I-097)
Affinity DataIC50: 0.700nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM561440(US11390625, Compound 8 | US11390625, Example 8)
Affinity DataIC50: 0.792nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM707526(US20240409609, Compound 51)
Affinity DataIC50: 0.795nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538120(US11253516, Example 22)
Affinity DataIC50: 0.800nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547814(WO2022090481, Example I-029)
Affinity DataIC50: 0.900nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547879(WO2022090481, Example I-098)
Affinity DataIC50: 0.900nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547807(WO2022090481, Example I-064 | WO2022090481, Exampl...)
Affinity DataIC50: 1nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547880(WO2022090481, Example I-099)
Affinity DataIC50: 1nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538125(US11253516, Example 27)
Affinity DataIC50: 1nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538131(US11253516, Example 33)
Affinity DataIC50: 1nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538132(US11253516, Example 34)
Affinity DataIC50: 1nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM538133(US11253516, Example 35)
Affinity DataIC50: 1nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701455(US20240352000, Example 1)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701456(US20240352000, Example 2)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701457(US20240352000, Example 3)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701458(US20240352000, Example 4)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701459(US20240352000, Example 5)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701460(US20240352000, Example 6)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701461(US20240352000, Example 7)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701462(US20240352000, Example 8)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701463(US20240352000, Example 9)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701466(US20240352000, Example 12)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701467(US20240352000, Example 13)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM701471(US20240352000, Example 17)
In DepthDetails

TargetEpidermal growth factor receptor [1-18,20-1210,T790M,C797S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM547810(WO2022090481, Example I-025)
Affinity DataIC50: 1.10nMAssay Description: Ba/F3 cells were ordered from DSMZ (ACC300, Lot17) and grown in RPMI-1640 (ATCC 30-2001) + 10 % FCS + 10 ng/ml IL-3 at 37 °C in 5 % CO2 atmosphere. ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

Displayed 1 to 50 (of 465 total ) | Next | Last >>
Jump to: